Research progress on the prognosis and treatment of hypersplenism after liver transplantation

doi:10.3877/cma.j.issn.1674-3903.2024.05.010

Abstract

Abstract:

Hypersplenism is a common complication in cirrhotic patients with portal hypertension. The main manifestations are splenomegaly and hemocytopenia. The outcome of patients with hypersplenism after liver transplantation is different due to the severity of the disease. At the same time， the treatment methods and principles of hypersplenism are different in different stages during liver transplantation. This article reviews the status quo of hypersplenism in liver cirrhosis， the changes of hypersplenism after liver transplantation， its potential mechanism and treatment， in order to provide reference for the diagnosis and treatment of hypersplenism resulted from cirrhosis.

Key words: Hypersplenism, Liver cirrhosis, Liver transplantation

Jian He, Li Zhang, Honghai Wang, Wentao Jiang. Research progress on the prognosis and treatment of hypersplenism after liver transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 310-314.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2024.05.010

https://zhyzzz.cma-cmc.com.cn/EN/Y2024/V18/I05/310

References 46

1	Jasso-Baltazar EA， Peãa-Arellano GA， Aguirre-Valadez J， et al.Portopulmonary hypertension：an updated review［J］. Transplant Direct， 2023， 9（8）：e1517.
2	Yoshida H， Shimizu T， Yoshioka M， et al. The role of the spleen in portal hypertension［J］. J Nippon Med Sch， 2023， 90（1）：20-25.
3	Gallo P， Terracciani F， Di Pasquale G， et al. Thrombocytopenia in chronic liver disease：physiopathology and new therapeutic strategies before invasive procedures［J］. World J Gastroenterol， 2022， 28（30）：4061-4074.
4	Lim HI， Cuker A. Thrombocytopenia and liver disease：pathophysiology and periprocedural management［J］. Hematology Am Soc Hematol Educ Program， 2022，（1）：296-302.
5	Yanaga K， Tzakis AG， Shimada M， et al. Reversal of hypersplenism following orthotopic liver transplantation［J］. Ann Surg， 1989， 210（2）：180-183.
6	Lu YF， Li XQ， Han XY， et al. Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism［J］. Asian Pac J Trop Med， 2013， 6（8）：663-666.
7	贺健，郭庆军，谢炎，等. 应用影像后处理技术测定脾体积评估原位肝移植缓解脾功能亢进的效果［J］. 中华器官移植杂志，2019， 40（2）：107-110.
8	夏强，沙朦. 活体肝移植的进展与展望［J］. 中华消化外科杂志，2022， 21（1）：39-42.
9	Coelho JC， Balbinot P， Nitsche R， et al. Change in platelet count in patients with hypersplenism subjected to liver transplantation［J］. Arq Gastroenterol， 2011， 48（3）：175-178.
10	Ishigami M， Ishizu Y， Onishi Y， et al. Long-term dynamics of hematological data and spleen volume in cirrhotic patients after liver transplantation-various dynamics depending on etiology［J］.Springerplus， 2013， 2：374.
11	Ikegami T， Soejima Y， Taketomi A， et al. Hypersplenism after living donor liver transplantation［J］. Hepatogastroenterology， 2009， 56（91-92）：778-782.
12	Matsuura T， Hayashida M， Saeki I， et al. The risk factors of persistent thrombocytopenia and splenomegaly after liver transplantation［J］.Pediatr Surg Int，2010，26（10）：1007-1010.
13	Stanca CM， Fiel MI， Aledort L， et al. Factors associated with persistent thrombocytopenia after liver transplantation［J］. Transplant Proc， 2010， 42（5）：1769-1773.
14	Chang JH， Choi JY， Woo HY， et al. Severe thrombocytopenia before liver transplantation is associated with delayed recovery of thrombocytopenia regardless of donor type［J］. World J Gastroenterol，2008， 14（37）：5723-5729.
15	贺健. 肝移植术后顽固性脾功能亢进预测因素的分析［D］. 天津：天津医科大学， 2019.
16	Kawano F， Ishizaki Y， Yoshimoto J， et al. Factors affecting persistent splenomegaly after adult-to-adult living donor liver transplantation using a left lobe［J］. Transplant Proc， 2019， 51（6）：1946-1949.
17	Nam NH， Taura K， Yao S， et al. Pretransplantation splenomegaly frequently persists after liver transplantation and can manifest as hypersplenism and graft fibrosis - a retrospective study［J］. Transpl Int， 2020， 33（12）：1807-1820.
18	Kilambi R， Singh AN， Madhusudhan KS， et al. Portal hypertension and hypersplenism in extrahepatic portal venous obstruction：are they related？［J］. Indian J Gastroenterol， 2018， 37（3）：202-208.
19	Xue Z， Zhang X， Li Z， et al. Analysis of portal vein thrombosis after liver transplantation［J］. ANZ J Surg， 2019， 89（9）：1075-1079.
20	Masuda Y， Yoshizawa K， Ohno Y， et al. Small-for-size syndrome in liver transplantation：definition， pathophysiology and management［J］. Hepatobiliary Pancreat Dis Int， 2020， 19（4）：334-341.
21	Takahashi K， Nagai S， Safwan M， et al. Thrombocytopenia after liver transplantation：should we care？［J］. World J Gastroenterol，2018， 24（13）：1386-1397.
22	Schwabl P， Seeland BA， Riedl F， et al. Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and noncirrhotic portal hypertension［J］. Adv Med Sci， 2022， 67（1）：154-162.
23	Qi RZ， Li ZW， Chang ZY， et al. Clinical efficacy of total laparoscopic splenectomy for portal hypertension and its influence on hepatic hemodynamics and liver function［J］. World J Gastrointest Surg， 2023， 15（8）：1684-1692.
24	Long B， Koyfman A， Gottlieb M. Complications in the adult asplenic patient：a review for the emergency clinician［J］. Am J Emerg Med，2021， 44：452-457.
25	Zhu J， Chen XJ， Hu XT，et al. A comparative study of surgical splenectomy， partial splenic embolization， and high-intensity focused ultrasound for hypersplenism［J］. J Ultrasound Med， 2016， 35（3）：467-474.
26	Huang Y， Ren D， Gao F， et al. An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis［J］. Minim Invasive Ther Allied Technol， 2022， 31（5）：664-675.
27	Slater SJ， Lukies M， Kavnoudias H， et al. Immune function and the role of vaccination after splenic artery embolization for blunt splenic injury［J］. Injury， 2022， 53（1）：112-115.
28	Capasso L， Moggio G， Camera A. Splenic artery embolization：a safety and save-life procedure in patient with acute leukemia，haemodynamically unstable because of haemoperitoneum［J］. Updates Surg， 2022， 74（4）：1489-1490.
29	Lee HL， Lee SW. The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension：advantages and pitfalls［J］. Clin Mol Hepatol， 2022， 28（2）：121-134.
30	Jiang X， Gao F， Ma Y， et al. Percutaneous microwave ablation in the spleen for treatment of hypersplenism in cirrhosis patients［J］.Dig Dis Sci， 2016， 61（1）：287-292.
31	Zhang X， Tang S， Huang G， et al. Minimally invasive treatment of cirrhotic secondary hypersplenism with high-intensity focused ultrasound［J］. Sci Rep， 2022， 12（1）：20700.
32	Tefferi A. Primary myelofibrosis：2023 update on diagnosis， riskstratification， and management［J］. Am J Hematol， 2023， 98（5）：801-821.
33	European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis［J］. J Hepatol， 2022， 76（5）：1151-1184.
34	尹宇航，许文涛，何福亮，等.《2022年欧洲肝病学会临床实践指南：预防和管理肝硬化患者出血和血栓形成》摘译［J］. 临床肝胆病杂志， 2022， 38（6）：4.
35	Roberts LN. How to manage hemostasis in patients with liver disease during interventions［J］. Hematology Am Soc Hematol Educ Program， 2023，（1）：274-280.
36	Evans CR， Cuker A， Crowther M， et al. Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease：a systematic review［J］. Res Pract Thromb Haemost， 2022， 6（4）：e12724.
37	Lindquist I， Olson SR， Li A， et al. The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures：a systematic review and meta-analysis［J］. Platelets， 2022， 33（1）：66-72.
38	Nag HH， Chandrasekar S， Manipadum JM， et al. Laparoscopic splenic artery ligation for hypersplenism in cirrhosis：a case series［J］. J Minim Access Surg， 2016， 12（4）：334-337.
39	Jo HS， Yu YD， Choi YJ， et al. Left liver graft in adult-to-adult living donor liver transplantation with an optimal portal flow modulation strategy to overcome the small-for-size syndrome- a retrospective cohort study［J］. Int J Surg， 2022， 106：106953.
40	Usai S， Colasanti M， Meniconi RL， et al. Splenic artery steal syndrome after liver transplantation - prophylaxis or treatment？ A case report and literature review［J］. Ann Hepatobiliary Pancreat Surg，2022， 26（4）：386-394.
41	Jiang WT， Yang J， Xie Y， et al. Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism ［J］. World J Gastroenterol， 2021， 27（7）：654-665.
42	Boillot O， Chopinet S， Gregoire E， et al. Partial splenectomy in children undergoing liver transplantation or venous shunt for severe hypersplenism：a case control comparative study［J］. Clin Res Hepatol Gastroenterol， 2022， 46（6）：101929.
43	Sibulesky L， Nguyen JH， Paz-Fumagalli R， et al. Treatment modalities for hypersplenism in liver transplant recipients with recurrent hepatitis C［J］. World J Gastroenterol， 2009， 15（40）：5010-5013.
44	D′Amico G， Partovi S， Del Prete L， et al. Proximal splenic artery embolization for refractory ascites and hydrothorax post-liver transplant［J］. Cardiovasc Intervent Radiol， 2023， 46（4）：470-479.
45	Ostojic A， Petrovic I， Silovski H， et al. Approach to persistent ascites after liver transplantation［J］. World J Hepatol， 2022， 14（9）：1739-1746.
46	Maruzzelli L， D′Amico M， Tuzzolino F， et al. Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients［J］. Eur Radiol， 2023， 33（4）：2612-2619.

[1]	Meini Ye, Sijia Liu, Yuwei Zang, Yunjian Liu. Research progress on portal vein thrombosis in liver cirrhosis [J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(05): 379-384.
[2]	Ningning Hu, Yanrong Zhao, Dong Wang, Shengliang Wang, Yuan Guo. The correlation study between the expression of FMNL3 and prognosis in hepatocellular carcinoma liver transplant recipients [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 283-288.
[3]	Fushun Zhong, Lu Yu, Xiaoli Fan, Qifa Ye. Liver transplantation for the treatment of hepatic epithelioid hemangioendothelioma：a case report [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 293-297.
[4]	Ranjia Liu, Xiangli Cui, Xiaozhu Zhou, Wei Qu, Zhijun Zhu. A systematic review of health-related quality of life assessment for pediatric liver transplant recipients [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(05): 302-309.
[5]	Shuxian Wang, Lianghao Zhang, Lijun Wang, Hui Zhang, Yuan Guo, Chuanshen Xu, Zhiqiang Li, Jinzhen Cai, Man Xie, We Rao. The establishment of predictive model and influencing factors of major adverse cardiovascular events during perioperative period of adult liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(04): 222-229.
[6]	Lina Zhang, Jiankun Xing, Liang Zhang, Yunsheng Li, Jing Wang, Liying Sun, Zhijun Zhu. Intraoperative anesthetic nusing care for infants undergoing living donor liver transplantation:a single-center experience [J]. Chinese Journal of Transplantation(Electronic Edition), 2024, 18(04): 235-238.
[7]	of Organ Transplantation of Chinese Medical Association Branch. Chinese practice guidelines for diagnosis and treatment of ischemic-type biliary lesion after liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 739-748.
[8]	Binsheng Fu, Xiao Feng, Qing Yang, Kaining Zeng, Jia Yao, Hui Tang, Jianrong Liu, Xuxia Wei, Huimin Yi, Shuhong Yi, Guihua Chen, Yang Yang. Application of donor liver with steatosis in adult split liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 789-794.
[9]	Zhihong Wei, Jianyong Liu, Xiaoya Wu, Fang Yang, Lizhi Lyu, Yi Jiang, Qiucheng Cai. Diagnosis and treatment of acute graft-versus-host disease after liver transplantation （report of four cases） [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 846-851.
[10]	Chinese Society of Organ Transplantation of Chinese Medical Association, Surgery Group of Chinese Society of Surgery of Chinese Medical Association, Transplantation Group of Chinese Society of Surgery of Chinese Medical Association, South China Alliance of Split Liver Transplantation. Chinese Clinical Practice Guidelines on Split Liver Transplantation in Children [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 593-601.
[11]	Wanyu Deng, Fu Chen, Leibo Xu. Comparison of postoperative recurrence-free survival and analysis of influencing factors between hepatitis B-associated hepatocellular carcinoma patients with and without liver cirrhosis [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 670-674.
[12]	Jun Liu, Wenjing Qiu, Fanghao Sun, Songying Li, Shuhong Yi, Binsheng Fu, Yang Yang, Hui Luo. Comparison of in vivo and in vitro split liver transplantation in pediatric liver transplantation [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 688-693.
[13]	Jian Cui, Qing Xia, Yun Lin, Guangling Li, Xinna Li, Wei Wang. Effects of platelet to lymphocyte ratio, immunoglobulin, myocardial enzyme spectrum and electrocardiogram parameters on the condition and prognosis of middle-aged and elderly patients with cirrhosis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(05): 400-406.
[14]	Xiangqing Qin, Chen Zhu, Haiyin Zhang. Construction of a normogram model for predicting the risk of esophageal and gastric varices bleeding in cirrhosis [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 330-335.
[15]	Yilong Liu, Rongguang Dang, Rong Ai, Kai Zhang. Establishment and validation of a model for the risk of rebleeding after endoscopic treatment in patients with cirrhosis and variceal bleeding [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(04): 336-342.

Please choose a citation manager

Content to export